Patents by Inventor Qingqing Lu

Qingqing Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240138186
    Abstract: A display panel includes a substrate, an active layer, a first metal layer and a second metal layer. The active layer is disposed on the substrate and includes a plurality of the driving active portions, and each driving active portion comprises a conductor sub-layer and a first semiconductor sub-layer. The first metal layer is disposed on a side of the active layer away from the substrate and includes a plurality of the driving gates, one of the plurality of the driving gates is correspondingly located on a side of the driving active portion away from the substrate. The second metal layer disposed on a side of the first metal layer away from the active layer and includes a plurality of the driving source electrodes and a plurality of the driving drain electrodes. The conductor sub-layer includes a first conductor sub-portion and a second conductor sub-portion arranged at intervals.
    Type: Application
    Filed: November 25, 2022
    Publication date: April 25, 2024
    Applicant: TCL China Star Optoelectronics Technology Co., Ltd.
    Inventors: Jiangbo YAO, Macai LU, Juan LIU, Shouqing CHEN, Qingqing OU
  • Patent number: 11261196
    Abstract: A salt serving as an Akt inhibitor and a crystal thereof, specifically related to a salt of the compound of formula (I) and a crystal thereof.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: March 1, 2022
    Assignee: HARBIN ZHENBAO PHARMACEUTICAL CO., LTD.
    Inventors: Gang Li, Lun Lu, Qingqing Lu, Lihong Hu, Charles Z. Ding
  • Publication number: 20210300873
    Abstract: The invention provides compositions containing a stable crystalline form of brequinar and methods of making such composition. The invention also provides methods of using such compositions to treat a condition in a subject.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 30, 2021
    Inventors: Abdolsamad Tadayon, Ping Huang, Chaoyi Deng, Jinsuo Yang, Siyi Jiang, Qingqing Lu, Lin Cui, Mo Jia, Xianjun You, David P. Hesson
  • Publication number: 20210292280
    Abstract: The invention provides compositions containing a stable crystalline form of brequinar and methods of making such composition. The invention also provides methods of using such compositions to treat a condition in a subject.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 23, 2021
    Inventors: Abdolsamad Tadayon, Ping Huang, Chaoyi Deng, Jinsuo Yang, Qingqing Lu, Lin Cui, Mo Jia, Xianjun You, David P. Hesson, Siyi Jiang
  • Patent number: 11124506
    Abstract: The present invention discloses to a hydrochloride salt, a citrate salt, a phosphate salt or a sulfate salt of compound 1, the crystal forms of the aforementioned salts, and a preparation method thereof. The present invention also relates their use in the preparation of a medicament for the treatment of cerebral apoplexy or epilepsy.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: September 21, 2021
    Assignee: HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY
    Inventors: Qingqing Lu, Shenyi Shi, Tiezhong Bai, Shujie Yuan, Zhengwu Li, Qiaofen Hu, Yijie Cao, Jing Gao, Hui Ding, Jinhua Li, Guanghai Xu, Zheng Wang, Xin Jin
  • Publication number: 20210087205
    Abstract: A salt serving as an Akt inhibitor and a crystal thereof, specifically related to a salt of the compound of formula (I) and a crystal thereof.
    Type: Application
    Filed: December 12, 2018
    Publication date: March 25, 2021
    Inventors: Gang LI, Lun LU, Qingqing LU, Lihong HU, Charles Z. DING
  • Publication number: 20190276475
    Abstract: The present invention discloses a crystal form and salt of a nitroimidazole compound, and a manufacturing method thereof. The invention further comprises an application of the crystal form and salt in preparing a pharmaceutical product for preventing and treating an infection caused by Mycobacterium tuberculosis or another microbe.
    Type: Application
    Filed: July 21, 2017
    Publication date: September 12, 2019
    Applicant: Medshine Discovery Inc.
    Inventors: Wei LUO, Charles Z. DING, Zhigang HUANG, Yinghu HU, Zongbin LI, Qingqing LU
  • Publication number: 20190169183
    Abstract: The present invention discloses to a hydrochloride salt, a citrate salt, a phosphate salt or a sulfate salt of compound 1, the crystal forms of the aforementioned salts, and a preparation method thereof. The present invention also relates their use in the preparation of a medicament for the treatment of cerebral apoplexy or epilepsy.
    Type: Application
    Filed: August 3, 2017
    Publication date: June 6, 2019
    Inventors: Qingqing Lu, Shenyi Shi, Tiezhong Bai, Shujie Yuan, Zhengwu Li, Qiaofen Hu, Yijie Cao, Jing Gao, Hui Ding, Jinhua Li, Guanghai Xu, Zheng Wang, Xin Jin